152 Search Results for: manufacturing

Igenza Collaboration with Syngenta Sees Advances in inABLE Biomanufacturing Technologies

Igenza’s collaboration with Syngenta reaches technical milestones as they develop efficient manufacturing technologies for innovative crop protection products. The collaboration capitalises on the inABLE suite of capabilities in gene expression, microbial strain improvement and bioprocess scale up. Syngenta will now develop the technology further. To read the full article, click here.

GSK affirms its long-term commitment to manufacturing in Scotland

The new £44 million facility at GSK Montrose will provide ingredients for over 400 million vaccinations a year. Significant investment in recent years re-affirms GSK’s belief that Scotland is an excellent base to manufacture and export to global markets. Built at a cost of £44M, the new facility at GSK’s site at Montrose in north-east Scotland will manufacture sterile aluminium salts which are compounds that...

Premier Manufacturing Location

Scotland has been demonstrated to be one of the most cost effective manufacturing locations in Europe and has a range of support mechanisms to derisk your investment. Scotland’s strong manufacturing tradition continues today: large multinationals and start ups manufacture a wide range of products in Scotland including fine chemicals, drugs, active ingredients, diagnostics and all the way to precision engineering components and medical devices. Scotland...

Scotland’s thriving life sciences sector defies predictions

Figures released today tracking the growth of Scottish life sciences suggest it is one of the nation’s fastest growing sectors, surpassing the turnover target set for it some five years earlier than forecast. The Scottish Government’s release of annual data on the nation’s life sciences cluster up to 2021 comes on the day Scotland’s life sciences community celebrates the achievements of its people and organisations...

Veranova Completes Mid-Scale API Expansion at Edinburgh, UK facility

Wayne, PA – Veranova’s subsidiary, Macfarlan Smith announced today the completion of a $10 million expansion of its mid-scale active pharmaceutical ingredient (API) manufacturing capabilities at its Edinburgh, UK facility. The multi-purpose asset, able to handle highly active APIs and intermediates, is positioned to enable growth in the generic opioid analgesic and anti-addiction markets, while also supporting the growing demands of Veranova’s existing customer base and...

SCOUT project delivers another successful year

Now two years since its launch, the Scottish Outreach (SCOUT) Project continues to demonstrate its value to an ever-increasing number of SME’s, by providing advice, support, and assistance towards driving innovation. SCOUT is a free service which aims to accelerate and de-risk the growth of Scottish SMEs in chemical, biochemical and life science sectors, who are seeking or developing disruptive technologies. Having engaged with 48...

Review of Precision Medicine landscape in Scotland

Scottish Enterprise and consultants SQW are currently reviewing the Precision Medicine landscape in Scotland. With attention increasingly focusing on implementation of precision medicine solutions in healthcare, we want to assess how well set up (or not) Scotland is for this to happen – looking from several perspectives: (i) data infrastructure; (ii) the general perception of precision medicine, inclusivity, messaging etc; (iii) opportunities for precision/companion diagnostics;...

Investment boost for Edinburgh life sciences firm rooted in world-famous Roslin Institute

RoslinCT, a leading Contract Development and Manufacturing Organization (CDMO) focused on advanced cell therapies, announces investment from Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in global healthcare. Established in 2006 in Edinburgh, Scotland, with support from Scottish Enterprise, RoslinCT was formed through an initial spin-out from the Roslin Institute, which has a famous track record in genetic and cellular biology....

Digital health investment confirmed as the first Moray Growth Deal project to get started

With a £5 Million capital investment from the UK Government, Scotland’s National Digital Health & Care Innovation Centre (DHI) – a collaboration between The Glasgow School of Art and the University of Strathclyde – is pleased to announce the first project to commence as part of the Moray Growth Deal is to deliver a Rural Centre of Excellence for Digital Health and Care Innovation. DHI...

Immerse partners with DTG to accelerate organisations in their digital transformation journey

Enterprise virtual reality (VR) software provider Immerse has today announced its new partnership with DTG, a digital transformation company that delivers technology and solutions that enable clients to embrace the operational, cultural and financial benefits of digitalisation. Virtual Reality is being used across organisations to transform the traditional ways in which we learn, explore, and interact. With a global customer base and customers such as...

Top